Regenerex Pharma (RGPX) 10-Q 16 Jul 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	31-May-14	Jul. 15, 2014
Document And Entity Information	'	'
Entity Registrant Name	'PEPTIDE TECHNOLOGIES, INC.	'
Entity Central Index Key	'0001357878	'
Document Type	'10-Q	'
Document Period End Date	31-May-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--11-30	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'Yes	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	151,158,000
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

Balance_Sheets_Unaudited

Balance Sheets (Unaudited) (USD $)	31-May-14	Nov. 30, 2013
Current assets	'	'
Cash and cash equivalents	$1,683	$157
Intangible assets and intellectual property	'	45,000
Website	4,166	5,833
Total assets	5,849	50,990
Current liabilities	'	'
Accounts payable and accrued liabilities	602,608	1,662,272
Notes payable	96,720	88,850
Total liabilities	699,328	1,751,122
Capital stock	'	'
Authorized:675,000,000 common shares, par value $0.001 Issued and outstanding: 31 May 2014 - 151,158,000 common shares 30 November 2013 - 151,123,000 common shares	151,158	151,123
Additional paid-in capital	183,244	148,279
Accumulated deficit	-105,837	-105,837
Accumulated deficit during development stage	-922,044	-1,893,697
Total stockholders' deficiency	-693,479	-1,700,132
Total stockholders' deficiency and liabilities	$5,849	$50,990

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	31-May-14	Nov. 30, 2013
Statement of Financial Position [Abstract]	'	'
Common shares Authorized	675,000,000	675,000,000
Common shares, par value	$0.00	$0.00
Common shares, Issued	151,158,000	151,123,000
Common shares, outstanding	151,158,000	151,123,000

Statements_of_Operations_Unaud

Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended		47 Months Ended
	31-May-14	31-May-13	31-May-14	31-May-13	31-May-14
Expenses	'	'	'	'	'
Consulting	'	$77,000	'	$152,000	$552,975
Salaries and bonus	157,404	159,000	315,344	318,000	1,385,428
General and administration	8,308	6,605	11,378	8,545	64,403
Professional fees	4,011	5,072	9,761	13,705	161,504
Supplies and materials	212	'	7,994	'	68,226
Net loss before other items	-169,935	-247,677	-344,477	-492,250	-2,232,536
Other items	'	'	'	'	'
Foreign exchange gain	-1,982	488	1,729	1,624	3,843
Interest expense	-713	-885	-1,599	-1,812	-9,351
Forgiveness of accounts payable	1,361,000	'	1,361,000	'	1,361,000
Write down of intangible assets and intellectual property	-45,000	'	-45,000	'	-45,000
Net loss for the period	1,143,370	-248,074	971,653	-492,438	-922,044
Foreign currency translation adjustment	'	'	'	'	-333
Total comprehensive loss for the period	$1,143,370	($248,074)	$971,653	($492,438)	($922,377)
Income (loss) per share from operations – Basic and diluted	$0.01	$0	$0.01	$0	'
Weighted average number of shares outstanding	151,152,341	149,858,439	151,143,249	149,470,376	'

Statements_of_Cash_Flows_Unaud

Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended		6 Months Ended		47 Months Ended
	31-May-14	31-May-13	31-May-14	31-May-13	31-May-14
OPERATING ACTIVITIES	'	'	'	'	'
Net loss for the period	$1,143,370	($248,074)	$971,653	($492,438)	($922,044)
Adjustments to reconcile net loss to cash used by operating	'	'	'	'	'
Accrued interest	713	885	1,599	1,812	9,351
Amortization	834	833	1,667	1,667	5,834
Foreign exchange gain	1,982	-488	-1,729	-1,624	-3,843
Forgiveness of accounts payable	-1,361,000	'	-1,361,000	'	-1,361,000
Non-cash consulting expense	'	'	'	'	2,000
Share-based payment	'	'	'	'	8,000
Write down of intangible assets and intellectual property	45,000	'	45,000	'	45,000
Changes in operating assets and liabilities	'	'	'	'	'
Decrease in prepaid expenses	'	'	'	3,494	2,709
Increase in accounts payable and accrued liabilities	136,916	222,433	301,336	459,678	1,962,859
Cash used in operating activities	-32,185	-24,411	-41,474	-27,411	-251,134
INVESTING ACTIVITIES	'	'	'	'	'
Purchase of website	'	'	'	'	-10,000
Cash used in investing activities	'	'	'	'	-10,000
FINANCING ACTIVITIES	'	'	'	'	'
Proceeds from issuance of common shares, net of share issuance costs	25,000	20,000	35,000	20,000	156,114
Increase (decrease) in notes payable	8,000	'	8,000	'	75,212
Contribution by related party	'	'	'	'	27,288
Cash from (used in) financing activities	33,000	20,000	43,000	20,000	258,614
Effect of foreign exchange rate changes on cash	'	'	'	'	-333
Increase (decrease) in cash and cash equivalents	815	-4,411	1,526	-7,411	-2,853
Cash and cash equivalents, beginning of period	868	4,780	157	7,780	4,536
Cash and cash equivalents, end of period	$1,683	$369	$1,683	$369	$1,683

Shareholders_Equity

Shareholders Equity (USD $)	Number of shares	Capital stock	Additional paid-in capital	Accumulated deficit	Accumulated deficit during development stage	Total
Balances, 30 November 2012 at Nov. 30, 2012	149,078,000	149,078	105,324	-105,837	-898,221	-749,656
Shares issued for Cash, net of share issuance costs (Note 8)	$45,000	$45	$42,955	'	'	$43,000
Contractor services (Note 8)	2,000,000	2,000	'	'	'	2,000
Net loss for the year	'	'	'	'	-995,476	-995,476
Balances, 30 November 2013	151,123,000	151,123	148,279	-105,837	-1,893,697	-1,700,132
Shares issued for cash (Note 8)	35,000	35	34,965	'	'	35,000
Net Income for the period	'	'	'	'	$971,653	$971,653
Balances, 31 May 2014 at May. 31, 2014	151,158,000	151,158	183,244	-105,837	-922,044	-693,479

NATURE_AND_CONTINUENCE_OF_OPER

NATURE AND CONTINUENCE OF OPERATIONS	6 Months Ended
	31-May-14
Notes to Financial Statements	'
NATURE AND CONTINUENCE OF OPERATIONS	'
		1	NATURE AND CONTINUANCE OF OPERATIONS
		1.1	Organization
	Peptide Technologies, Inc. (the “Company”) was incorporated in the State of Nevada, United States of America, on 18November 2005. On 29July 2010, the Company’s name was changed from Online Originals, Inc. to CREEnergy Corporation. Effective 12October 2011, the Company’s name was changed from CREEnergy Corporation to Peptide Technologies, Inc. The Company’s year-end is 30November. The Company is currently a development stage Company.
	On 5August 2013, the Company incorporated Pept Peptide Technologies Inc. (“Pept Peptide”), a wholly-owned subsidiary, under the laws of British Columbia. Pept Peptide currently does not have any transactions from the date of incorporation on 5August 2013 to 31 May 2014.
		1.2	Nature of Operations and Change in Business
	Upon inception on 18November 2005, the Company’s business plan was to develop a membership-based website art gallery/auction house specifically focused on displaying and selling original artwork. The Company changed its status from a development stage company to an operating company on 30November2009. Management realized that the results of operations from the sale of artwork lacks luster and decided to change the Company’s business focus and plan for other strategic opportunities. Effective 26June2010, the Company became a development stage company focusing on a new business.
	On 23 August 2011, the Company entered into an agreement (the “Asset Purchase Agreement”) in which the Company, in exchange for 75,000,000 shares of the Company’s restricted common stock, received all rights and title to proprietary technologies and formulas involving the application of specialty Peptides. The Company has changed its business focus to the manufacturing and distribution of natural peptide solutions to combat the economic burden of bio-fouling. On 14 December 2011, the Company amended the Asset Purchase Agreement (the “First Amendment”). As a result of the First Amendment, the purchase price of the assets was reduced from 75,000,000 shares to 45,000,000 shares, and 30,000,000 shares were returned to treasury (Note 7).
	On 1 May 2014, the Company entered into an agreement whereby theAsset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor (Note7).
	The Company’s business activities focus is on the development of all-natural, sustainable solutions to the increasing problem of bio-fouling and the development of safe “green” organic-based fouling prevention products used to combat the rapidly growing problems caused by the attachment of hard fouling agents inmarine and freshwater environments. This approach emphasizes minimizing the attachment of hard fouling agents (mussels, barnacles, etc.) and preventing the build-up of any bio-film layer as well.
		1.3	Basis of Going Concern
	The accompanying interim consolidated financial statements as at 31 May 2014 and for the six month period then ended have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities and commitments in the normal course of business. The Company has net income of $971,653 for the six month period ended 31 May 2014 (31 May 2013–loss of $492,438; cumulative loss - $922,044) and has a working capital deficit of $697,645 at 31 May 2014 (30 November 2013 - $1,750,965).
	Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive,or raise additional debt and/or equity capital. Management believes that the Company’s capital resources should be adequate to continue operating and maintaining its business strategy during the fiscal year ended 30 November 2014. However, if the Company is unable to raise additional capital in the near future or met financing requirements, due to the Company’s liquidity problems, management expects that the Company will need to curtail operations, liquidate assets, seek additional capital on less favorable terms and/or pursue other remedial measures. Management is aware, in making its assessment, of material uncertainties related to events or conditions that may cast significant doubt upon the Company’s ability to continue as a going concern. These interim consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
	Although management is actively seeking to add new products and/or services in order to show profitability, and is seeking additional sources of equity or debt financing, there is no assurance that these activities will be successful. The Company has not yet been able to find products and services that would contribute to their businessdue to the continued economic condition. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The interim consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
		1.4	Unaudited Statements
	While the information presented in the accompanying interim consolidated financial statements is unaudited, it includes all adjustments which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Except as disclosed below, these interim consolidated financial statements follow the same accounting policies and methods of their application as the Company’s audited 30November 2013 annual consolidated financial statements. It is suggested that these interim consolidated financial statements be read in conjunction with the Company’s audited consolidated financial statements for the year ended 30November 2013, included in the annual report previously filed with the Securities and Exchange Commission on Form 10-K. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.
	The information as of 30November2013, is taken from the audited consolidated financial statements as of that date.

SIGNIFICANT_ACCOUNTING_POLICIE

SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	31-May-14
Accounting Policies [Abstract]	'
SIGNIFICANT ACCOUNTING POLICIES	'
	This summary of significant accounting policies is presented to assist in understanding the Company’s interim consolidated financial statements. The interim consolidated financial statements and notes are representations of management who is responsible for their integrity and objectivity. These accounting policies have been consistently applied in the preparation of the interim consolidated financial statements.
		2.1	Basis of Presentation
	These interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) applicable for a development stage company for financial information and are expressed in U.S. dollars.
		2.2	Principles of Consolidation
			These interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary Pept Peptide, a company incorporated in the province of British Columbia on 5 August 2013. All significant inter-company balances and transactions have been eliminated upon consolidation.
		2.3	Organizational and Start-up Costs
	Costs of start-up activities, including organizational costs, are expensed as incurred in accordance with Accounting Standards Codification (“ASC”) 720-15, “Start-Up Costs”.
		2.4	Development-Stage Company
	During the year ended 30 November 2010, the Company abandoned its previous business of sale of original artwork and re-entered the development stage with its intended new business, which currently has no revenues.  Management expects to sustain losses from operations until such time it can generate sufficient revenues to meet its anticipated cost structure. The Company is considered a development-stage company in accordance with the ASC 915, “Accounting and Reporting by Development-Stage Enterprises”.A development-stage enterprise is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.
		2.5	Cash and Cash Equivalents
	Cash and cash equivalents include highly liquid investments with original maturities of three months or less.
		2.5	Website
	In accordance with ASC 350-50, “Website Development Costs”, expenditures during the planningand operating stages of the Company’s website are expensed as incurred. Expenditures incurred during the website application and infrastructure development stage are capitalized and amortized to expense over the website’s estimated useful life of 3 years.
		2.7	Intangible Assets
	Intangible assets include the cost of acquiring the intellectual property. In accordance with ASC 350-30 “General Intangibles Other Than Goodwill”, an intangible asset that is acquired either individually or with a group of other assets shall be recognized. Costs of internally developing, maintaining, or restoring intangible assets that are not specifically identifiable, that have indeterminate lives, or that are inherent in a continuing business and related to an entity as whole, shall be recognized as an expense when incurred. The intellectual property is determined to have an indefinite useful life and is not subject to amortization. The useful life of the intangible asset is reassessed at each reporting period.
		2.8	Impairment of Long-Lived Assets
	Long-lived assets include the website and intangible assets and intellectual property. Long-lived assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets not subject to amortization are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount of the asset exceeds the fair value of the asset. There has been no impairment as of 31 May 2014.
		2.9	Research and Development
	Research and development expenses are charged to operations as incurred.
		2.1	Income Taxes
	The Company adopted the ASC 740, “Accounting for Income Taxes”. ASC 740 requires the use of the asset and liability method of accounting of income taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the interim consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.
		2.11	Basic and Diluted Income (Loss) per Share
	In accordance with ASC 260, “Earnings per Share”, the basic income (loss) per common share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed similar to basic income (loss) per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings per share are not shown for periods in which the Company incurs a loss because it would be anti-dilutive. At 31 May 2014, the Company had no stock equivalents that were anti-dilutive and excluded in the earnings (loss) per share computation.
		2.12	Estimated Fair Value of Financial Instruments
	The carrying value of the Company’s interim consolidated financial instruments, consisting of cash, accountspayable and notes payable approximate their fair value due to the short-term maturity of these instruments. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or currency risks arising from these financial instruments.
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. At 31 May 2014, all cash and cash equivalents were insured by agencies of the U.S. Government.
		2.13	Foreign Currency Translation
	The interim consolidated financial statements are presented in U.S. dollars. In accordance with ASC 830 “Foreign Currency Matters”, foreign denominated monetary assets and liabilities are translated to their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the period. Related translation adjustments are reported as a separate component of stockholders’ equity, whereas gains or losses resulting from foreign currency transactions are included in results of operations.
		2.14	Comprehensive Income (Loss)
	The Company adopted ASC 220, "Reporting Comprehensive Income". ASC 220 requires that the components and total amounts of comprehensive income (loss) be displayed in the interim consolidated financial statements beginning in 1998. Comprehensive income (loss) includes net income (loss) and all changes in equity during a period that arises from non-owner sources, such as foreign currency items and unrealized gains and losses on certain investments in equity securities.
		2.15	Use of Estimates
	The preparation of the Company’s interim consolidated financial statements are in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the amounts reported in these interim consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
		2.16	Changes in Accounting Policy
	Effective 1 December 2013, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”)No. 2013-02, “Comprehensive Income”. This update requires an entity to present information about amounts reclassified out of accumulated other comprehensive income and their corresponding effect on the respective line items in net income in one place, and in some cases, cross-references to related footnote disclosures. The update applies to public companies for all reporting periods presented, including interim periods, and to nonpublic entities for annual reporting periods. ASU No. 2013-02 will be effective for fiscal years, and interim periods within those years, beginning after 15 December 2012 for public companies, with early adoption permitted. The adoption of this update did not have a material effect on the Company’s interim consolidated financial statements.
		2.17	Recent Accounting Pronouncements
	In July 2013, the FASB issued ASU No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”, which is intended to eliminate the diversity that is in practice with regard to the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU No. 2013-11 is effective for fiscal years and interim periods within those years, beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.
	In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers”, which provides a five-step approach to be applied to all contracts with customers. ASU No. 2014-09also requires expanded disclosures about revenue recognition. ASU No. 2014-09 is effective for annual reporting periods beginning after 15 December 2016, including interim periods. Early adoption is not permitted. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.
	In June 2014, the FASB issued ASU No. 2014-10, “Development Stage Entities”, which intendsto remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the update eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. ASU No. 2014-10 is effective for fiscal years and interim periods beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.
		2.18	Reclassifications
	Certain amounts reported in previous periods have been reclassified to conform to the current presentation.
		2.19	Other
	The Company consists of one reportable business segment.
	The Company paid no dividends during the periods presented.

WEBSITE

WEBSITE	6 Months Ended
	31-May-14
Notes to Financial Statements	'
WEBSITE	'
		1	WEBSITE
	As at:	31-May-14			30-Nov-13
					(Audited)
		Cost	Accumulated amortization	Net book value	Cost	Accumulated amortization	Net book value
		$	$	$	$	$	$
	Website	10,000	5,834	4,166	10,000	4,167	5,833
	Total	10,000	5,834	4,166	10,000	4,167	5,833
	The Company purchased a website during October 2012 for $10,000. This website has a useful life of threeyears, and the cost is being amortized over the life of the asset. During the six month periodended31 May 2014, the Company recognized amortization expense of $1,667 (31 May 2013- $1,667; cumulative - $5,834) (Note 9).

ACCOUNTS_PAYABLE_AND_ACCRUED_L

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	6 Months Ended
	31-May-14
Notes to Financial Statements	'
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	'
	As at:	31-May	30-Nov-13
		2014	(Audited)
		$	$
	Accounts payable	28,180	574,188
	Accrued liabilities	14,000	27,000
	Payroll taxes payable	26,428	17,084
	Salaries and benefits payable (Note 6)	534,000	1,044,000
	Total accounts payable and accrued liabilities	602,608	1,662,272
	Trades payable and accrued liabilities are non-interest bearing, unsecured and have settlement dates within one year.
	On 27 May 2014, the Chief Executive Officer (“CEO”) requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 May 2014(Notes 6 and 12).
	On 27 May 2014, aconsultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000 (Notes 6 and 12).
	The Company is in the process of completing and resolving issues related to its income tax filings and has accrued $10,000 during the year ended 30 November 2013 related to potential penalties associated with these filings. However, there is no assurance that additional interest and penalties will not be assessed(Notes10 and 11).

NOTES_PAYABLE_AND_ACCRUED_INTE

NOTES PAYABLE AND ACCRUED INTEREST	6 Months Ended
	31-May-14
Notes to Financial Statements	'
NOTES PAYABLE AND ACCRUED INTEREST	'
	As at:	31-May-14	30-Nov-13
		$	(Audited)
			$
	During the year ended 30 November2010, Fotoview Inc. (“Fotoview”) issued a loan of $16,000 to a former director of the Company to purchase 4,000,000 restricted common shares of the Company.  Upon the director’s resignation, the 4,000,000 common shares were cancelled and the Company assumed the loan payable to Fotoview.  The loan is unsecured, bears no interest, and has no fixed terms of repayment.	16,000	16,000
	On 21 September2011, PSI Services (“PSI”) issued a loan of $500 to the Company. The loan is unsecured, bears no interest and has no fixed terms of repayment.	500	500
	On 13November2011, PSI issued a loan of CAD$45,000 to the Company.  The loan is unsecured and bears interest at a rate of 6% per annum. Principal and accrued interest aredue on 30November2014.  During the six month period ended 31 May 2014, the Company accrued interest expense of $1,107(31 May 2013 - $1,254) (Note 12).  The loan payable to PSI as at 31 May 2014consists of principal and accrued interest of $41,512 (30 November2013–$42,710) and $6,347 (30 November2013–$5,251), respectively.	47,859	47,961
	On 1June2012, PSI issued a loan of CAD$20,000 to the Company.  The loan is unsecured and bears interest at a rate of 6% per annum.  Principal and accrued interest is due on 30November2014.  During the six months ended 31 May 2014, the Company accrued interest expense of $492(31 May 2013- $558) (Note 12).The loan payable to PSI as at 31 May 2014 consists of principal and accrued interest of $18,450 (30 November2013–$18,982) and $2,211 (30 November2013–$1,707), respectively.	20,661	20,689
	On 22 October2013, PSI issued a loan of USD$3,700 to the Company. The loan is unsecured, bears no interest, and has no fixed terms of repayment.	3,700	3,700
	On 21 April 2014, PSI issued a loan of USD$8,000 to the Company.  The loan is unsecured, bears no interest, and has no fixed terms of repayment.	8,000	-
	Total notes payable	96,720	88,850

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	31-May-14
Related Party Transactions [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	As at 31 May 2014, the amount due to related parties includes $534,000(30 November 2013 - $1,044,000)payable to directors and employees of the Company in relation to salaries and benefits earned, and $240 (30 November 2013 - $730) payable to the Chief Financial Officer (“CFO”)of the Company in relation to expense reimbursements.Of the amount due to related parties, $Nil relates to bonuses payable to the CEO of the Company (30 November 2013 - $300,000) (Note 4).
	During the six month periodended 31 May 2014, the Company accrued salaries and benefits of $306,000 to officers and employees of the Company (31 May 2013- $306,000; cumulative - $1,359,000).
	On 27 May 2014, the CEO requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 May 2014. As at 31 May 2014, included in salaries and benefits are bonuses of $Nil accrued to the CEO of the Company during the six month periodended 31 May 2014 (31 May 2013 - $Nil; cumulative - $300,000)(Notes 4 and 12).
	Effective 1 December 2013, the Company and a former related party consultant mutually terminated an Advisory Agreement entered into on 1 November 2012. The Company accrued $Nil of consulting fees to the consultant (31 May 2013 - $150,000; cumulative - $545,000) during the six month period ended 31 May 2014.
	On 27 May 2014, a consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000. As at 31 May 2014 there is $Nil (30 November 2013 - $545,000) outstanding and payable to the consultant for consulting services received (Notes 4 and 12).
	During the year ended 30 November 2013, the Board approved a commission payment program (the “Program”) equal to 30% of gross sales of fouling prevention coatings. Under this Program, the CEO will receive compensation equal to 20% of gross sales of anti-fouling paint, as recognition of his work in developing the formulas; and an external consultant will receive 10% of gross sales of anti-fouling paint as compensation for sales development.On 28 February 2014, the Board amendedtheProgram to reduce the CEO’s compensation from 20% to 10% of gross sales of anti-fouling paint.On 27 May 2014, the Program was eliminated by mutual agreement from both parties affected. As a result, no commissions will be earned by either the CEO or the applicable consultant on gross sales of fouling prevention coatings. As at 31 May 2014, there were $Nil commissions earned(Note 7).
	During the six month period ended 31 May 2014, directors and shareholders of the Company made cash contributions in the amount of $Nil (31 May 2013 - $Nil, cumulative – $27,288).

INTANGIBLE_ASSETS_AND_INTELLEC

INTANGIBLE ASSETS AND INTELLECTUAL PROPERTY	6 Months Ended
	31-May-14
Notes to Financial Statements	'
INTANGIBLE ASSETS AND INTELLECTUAL PROPERTY	'
	On 23 August 2011, the Company entered into an Asset Purchase Agreement to acquire intangible assets and intellectual property known as the Platforms in exchange for 75,000,000 restricted common shares of the Company (issued on 23 August 2011) (Note 1).
	On 14 December 2011, the Company entered into an amendedthe First Amendmentand, as a result, a total of 30,000,000 restricted common shares of the Company were returned to treasury and cancelled in exchange for payment of half of one percent of all gross monies received by the Company in relation to revenue earned from products derived from the use of all the formulae listed in the Asset Purchase Agreement. In addition, a monthly stipend of CAD $15,000 per month is to be paid commencing on the receipt of monies from the first contract signed to purchase products derived from the use of the formulae for a period of five years from the date of the First Amendment. The cancellation of 30,000,000 common shares has been recorded as a recovery of intangible assets and intellectual property (Note 1).
	On 1 May 2014, the Company entered into an agreement whereby theAsset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor (Note 1).
	During the six month period ended 31 May 2014, the Company recorded a write down of $45,000 (31 May 2013 - $Nil; cumulative - $45,000) related to its intangible assets and intellectual property (Note 12).
	On 20 January 2013, the Board approved theProgram equal to 30% of gross sales of fouling prevention coatings. Under this Program, the CEO will receive compensation equal to 20% of gross sales of anti-fouling paint, as recognition of his work in developing the formulas; and an external consultant will receive 10% of gross sales of anti-fouling paint as compensation for sales development. On 28 February 2014, the Board amended the Program to reduce the CEO’s compensation from 20% to 10% of gross sales of anti-fouling paint. On 27 May 2014, the Program was eliminated by mutual agreement from both parties affected. As a result, no commissions will be earned by either the CEO or the applicable consultant on gross sales of fouling prevention coatings. As of 31 May 2014, there were $Nil commissions earned(Note 6).

CAPITAL_STOCK

CAPITAL STOCK	6 Months Ended
	31-May-14
Notes to Financial Statements	'
CAPITAL STOCK	'
		8.1	Authorized common stock
	The Company’s authorized common stock consists of 675,000,000 shares of common stock with a par value of $0.001 per share. On 10 August2010, the Company increased the number of authorized share capital from 75,000,000 shares of common stock to 675,000,000 shares of common stock with the same par value of $0.001 per share.
		8.2	Issued and outstanding
	On 2 June2010, and effective 10 August 2010, the directors of the Company approved a forward split of the common stock of the Company on a basis of 30 new common shares for 1 old common share. As a result of the forward stock split, 208,800,000 additional shares were issued. Capital and additional paid-in capital have been adjusted accordingly. When adjusted retroactively, there was a $119,501 shortage of additional paid-in capital; thus an adjustment to accumulated deficit of $104,000 was recorded on 20 May 2010 (the date of issuance of 120,000,000 shares) and $15,501 to the beginning balance. The interim consolidated financial statements contained herein reflect the appropriate values for capital stock and accumulated deficit. Unless otherwise noted, all references in the accompanying interim consolidated financial statements to the number of common shares and per share amounts have been retroactively restated to reflect the forward stock split.
	The total issued and outstanding capital stock is 151,158,000 common shares with a par value of $0.001 per common share. The Company’s common stock issuances to date are as follows:
		a)	On 10 April 2013, the Company issued 20,000 shares of the Company’s restricted common stock for cash proceeds of $20,000. The Company paid $2,000 in share issuance costs.
		b)	On 26 April 2013, the Company issued 2,000,000 shares of the Company’s restricted common stock at a par value of $0.001 per share to a third party for marketing assistance with the development of the international markets in the South Pacific quadrant for the Company. As a result, the Company recorded consulting expense of $2,000 when the stock was issued (Note12).
		c)	On 18 July 2013, the Company issued 25,000 shares of the Company’s restricted common stock for cash proceeds of $25,000.
		d)	On 3 December 2013, the Company issued 10,000 shares of the Company’s restricted common stock for cash proceeds of $10,000.
		e)	On 3 March 2014, the Company issued 10,000 shares of the Company’s restricted common shares for cash proceeds of $10,000.
		f)	On 11 March 2014, the Company issued 5,000 shares of the Company’s restricted common shares for cash proceeds of $5,000.
		g)	On 3 April 2014, the Company issued 10,000 shares of the Company’s restricted common stock for cash proceeds of $10,000.

GENERAL_AND_ADMINISTRATION_EXP

GENERAL AND ADMINISTRATION EXPENSES	6 Months Ended
	31-May-14
Notes to Financial Statements	'
GENERAL AND ADMINISTRATION EXPENSES	'
		Three month period ended 31 May 2014	Six month period ended 31 May 2014	Three month period ended 31 May 2013	Six month period ended 31 May 2013	Cumulative from re-entering of development stage on
		$	$	$	$	26-Jun-10
						to 31 May 2014
						$
	Administration	-	-	-	-	20
	Amortization (Note 3)	834	1,667	833	1,667	5,834
	Bank charges	51	134	84	156	1,418
	Dues and subscription	-	-	-	-	575
	Filing fees	5,257	5,978	3,203	3,228	17,448
	Meals and entertainment	-	-	-	-	254
	Office	431	500	132	329	7,223
	Penalties	-	-	-	-	10,000
	Transfer agent	255	550	90	240	4,051
	Rent	223	492	545	738	1,725
	Share-based payment	-	-	-	-	8,000
	Telecommunication	1,257	2,057	621	682	5,050
	Travel	-	-	1,097	1,505	2,656
	Website	-	-	-	-	149
	Total general and administration expenses	8,308	11,378	6,605	8,545	64,403

INCOME_TAXES

INCOME TAXES	6 Months Ended
	31-May-14
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
		10.1	Provision for income taxes
	Income tax expense differs from the amount that would result from applying the federal income tax rate to earnings before income taxes. During thesix monthperiods ended 31 May 2014 and 2013, these differences result from the following items:
		For the six monthperiod ended 31 May 2014	For the six monthperiod ended31 May 2013
		$	$
	Income (loss) before income taxes	971,653	-492,438
	Federal income tax rates	35.00%	35.00%
	Income tax expense (recovery) based on the above rates	340,079	-172,353
	Non–deductible items	15,750	-
	Change in valuation allowance	-355,829	172,353
	Income tax expense	-	-
		10.2	Deferred tax balances
	The composition of the Company’s deferred tax assets as at 31 May 2014 and 30 November 2013are as follows:
	As at:	31-May	30-Nov-13
		2014	(Audited)
		$	$
	Net income tax operating loss carry-forward	959,254	1,975,908
	Deferred tax assets	335,739	691,568
	Valuation allowance	-335,739	-691,568
	Deferred tax assets (liabilities)	-	-
	As at 31 May 2014, the Company has a total non-capital loss carry forward balance of $959,254 (30 November 2013 - 1,975,908), which has expiry dates between the years of 2025 to 2034.
	The Company’s recognized and unrecognized deferred tax assets related to the unused tax losses. A full valuation allowance has been recorded against the potential deferred tax assets associated with all the loss carry-forwards as their utilization is not considered more likely than not at this time.
	The Company is in the process of completing and resolving issues related to its income tax filings and has accrued $10,000 during the year ended 30 November 2013 related to potential penalties associated with these filings. However, there is no assurance that additional interest and penalties will not be assessed (Notes 4 and 11).

COMMITMENTS_AND_CONTINGENCY

COMMITMENTS AND CONTINGENCY	6 Months Ended
	31-May-14
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCY	'
		a)	On 11 December 2012, the Company formerly engaged BB&T Capital Markets ("BB&TCM") to act as the Company's exclusive financial advisor and agent in connection with developing strategic alternatives for the Company regarding debt financings, licensing of intellectual properties developed by the Company, equity raises, sale of intellectual properties, or other capital markets transactions that may develop over the course of a 24-month agreement (the “Agreement”)
			The Company is to pay BB&TCM an advisory fee of three percent of the face amount of the financial transactions advised upon during the course of the engagement, due and payable at closing of any contemplated transactions under the engagement.
			Additionally, the Company is to defend, indemnify and hold BB&TCM, its parent company, subsidiaries and affiliates and its and their directors, officers, employees, agents and successors and assigns harmless from and against any losses, suits, actions, claims, damages, costs and or other liabilities which any indemnified person may incur as a result of acting on behalf of the Company in connection with this engagement.
	On 19 May 2014, the Company renewed/extended the Agreement with BB&T Capital Markets. The extension runs from 1 May 2014 through 1 May 2016 (24 months). All other provisions of the Agreement remain unchanged.
		b)	On 26 May 2014, the Company entered into an exclusive global distribution agreement with All-Sea Coatings Ltd. (a division of All-Sea Enterprises) of North Vancouver, Canada. The agreement grants to All-Sea Coatings Ltd. the exclusive rights to establish all aspects of the commercialization of the Company’s intangible assets and intellectual propertyrelated to all-natural and sustainable organic-based fouling prevention coatings and any related sales.
		c)	The Company is in the process of completing certain of its income tax filings and has accrued $10,000 during the year ended 30 November 2013 related to potential penalties associated with these filings. However, there is no assurance that additional interest and penalties will be assessed (Notes 4 and 10).
		d)	The Company is committed to making payments related to its notes payable (Note 5).

SUPPLEMENTAL_CASH_FLOW_INFORMA

SUPPLEMENTAL CASH FLOW INFORMATION	6 Months Ended
	31-May-14
Notes to Financial Statements	'
SUPPLEMENTAL CASH FLOW INFORMATION	'
	The Company made the following cash payments for interest and income taxes:
		Three month period ended 31 May 2014	Six month period ended 31 May 2014	Three month period ended 31 May 2013	Six month period ended 31 May 2013
		$	$	$	$
	Interest paid	-	-	-	-
	Taxes paid	-	-	-	-
	Total cash payments	-	-	-	-
	On 26 April 2013, the Company issued 2,000,000 fully vested shares of the Company’s restricted common stock at a par value of $0.001 per share to a third party for marketing assistance with the development of the international markets in the South Pacific quadrant for the Company. As a result, the Company recorded consulting expenseof $2,000 when the stock was issued (Note 8).
	During the six month periodended 31 May 2014, the Company accrued interest expense of $1,107(31 May 2013 - $1,254) in relation to a loan of CAD$45,000 issued by PSI on 13 November 2011. The loan is unsecured and bears interest at a rate of 6% per annum (Note 5).
	During the six month period ended 31 May 2014, the Company accrued interest expense of $492(31 May 2013 - $558) in relation to a loan of CAD$20,000 issued by PSI on 1 June 2012. The loan is unsecured and bears interest at a rate of 6% per annum (Note 5).
	During the six month period ended 31 May 2014, the Company recorded a write down of $45,000 (31 May 2013 - $Nil; cumulative - $45,000) related to its intangible assets and intellectual property (Note 7).
	On 27 May 2014, the CEO requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 May 2014(Notes4 and 6).
	On 27 May 2014, aconsultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000 (Notes 4 and 6).

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	31-May-14
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	There have been no reportable eventswhich have occurred during the period from the six month period ended 31 May 2014 to the date the interim consolidated financial statements were available to be issued on 5 July2014.

SIGNIFICANT_ACCOUNTING_POLICIE1

SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	31-May-14
Accounting Policies [Abstract]	'
Basis of Presentation	'
	2.1        Basis of Presentation
		These interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) applicable for a development stage company for financial information and are expressed in U.S. dollars.
Principles of Consolidation	'
	2.2        Principles of Consolidation
		These interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary Pept Peptide Technologies Inc., a company incorporated in the province of British Columbia on 5 August 2013. All significant inter-company balances and transactions have been eliminated upon consolidation.
Organizational and Start-up Costs	'
	2.3        Organizational and Start-up Costs
	Costs of start-up activities, including organizational costs, are expensed as incurred in accordance with Accounting Standards Codification (“ASC”) 720-15, “Start-Up Costs”.
Development-Stage Company	'
	2.4        Development-Stage Company
	During the year ended 30 November 2010, the Company abandoned its previous business of sale of original artwork and re-entered the development stage with its intended new business, which currently has no revenues.  Management expects to sustain losses from operations until such time it can generate sufficient revenues to meet its anticipated cost structure. The Company is considered a development-stage company in accordance with the ASC 915, “Accounting and Reporting by Development-Stage Enterprises”. A development-stage enterprise is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.
Cash and Cash Equivalents	'
	2.5        Cash and Cash Equivalents
	Cash and cash equivalents include highly liquid investments with original maturities of three months or less.
Website	'
	2.6        Website
	In accordance with ASC 350-50, “Website Development Costs”, expenditures during the planning and operating stages of the Company’s website are expensed as incurred. Expenditures incurred during the website application and infrastructure development stage are capitalized and amortized to expense over the website’s estimated useful life of 3 years.
Intangible Assets	'
	2.7        Intangible Assets
	Intangible assets include the cost of acquiring the intellectual property. In accordance with ASC 350-30 “General Intangibles Other Than Goodwill”, an intangible asset that is acquired either individually or with a group of other assets shall be recognized. Costs of internally developing, maintaining, or restoring intangible assets that are not specifically identifiable, that have indeterminate lives, or that are inherent in a continuing business and related to an entity as whole, shall be recognized as an expense when incurred. The intellectual property is determined to have an indefinite useful life and is not subject to amortization. The useful life of the intangible asset is reassessed at each reporting period.
Impairment of Long-Lived Assets	'
	2.8        Impairment of Long-Lived Assets
	Long-lived assets include the website and intangible assets and intellectual property. Long-lived assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets not subject to amortization are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount of the asset exceeds the fair value of the asset. There has been no impairment as of 31 May 2014.
Research and Development	'
	2.9        Research and Development
	Research and development expenses are charged to operations as incurred.
Income Taxes	'
	2.10    Income Taxes
	The Company adopted the ASC 740, “Accounting for Income Taxes”. ASC 740 requires the use of the asset and liability method of accounting of income taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the interim consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.
Basic and Diluted Income (Loss) per Share	'
	2.11    Basic and Diluted Income (Loss) per Share
	In accordance with ASC 260, “Earnings per Share”, the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings per share are not shown for periods in which the Company incurs a loss because it would be anti-dilutive. At 31 May 2014, the Company had no stock equivalents that were anti-dilutive and excluded in the earnings per share computation.
Estimated fair value of financial instruments	'
	2.12    Estimated fair value of financial instruments
	The carrying value of the Company’s interim consolidated financial instruments, consisting of cash, accounts payable and notes payable approximate their fair value due to the short-term maturity of these instruments. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or currency risks arising from these financial instruments.
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. At 31 May 2014, all cash and cash equivalents were insured by agencies of the U.S. Government.
Foreign Currency Translation	'
	2.13    Foreign Currency Translation
	The interim consolidated financial statements are presented in U.S. dollars. In accordance with ASC 830 “Foreign Currency Matters”, foreign denominated monetary assets and liabilities are translated to their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the period. Related translation adjustments are reported as a separate component of stockholders’ equity, whereas gains or losses resulting from foreign currency transactions are included in results of operations.
Comprehensive Income (Loss)	'
	2.14    Comprehensive Income (Loss)
	The Company adopted ASC 220, "Reporting Comprehensive Income". ASC 220 requires that the components and total amounts of comprehensive income be displayed in the interim consolidated financial statements beginning in 1998. Comprehensive income includes net income and all changes in equity during a period that arises from non-owner sources, such as foreign currency items and unrealized gains and losses on certain investments in equity securities.
Use of Estimates	'
	2.15    Use of Estimates
	The preparation of the Company’s interim consolidated financial statements are in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Changes in Accounting Policy	'
	2.16    Changes in Accounting Policy
	Effective 1 December 2013, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2013-02, “Comprehensive Income”. This update requires an entity to present information about amounts reclassified out of accumulated other comprehensive income and their corresponding effect on the respective line items in net income in one place, and in some cases, cross-references to related footnote disclosures. The update applies to public companies for all reporting periods presented, including interim periods, and to nonpublic entities for annual reporting periods. ASU No. 2013-02 will be effective for fiscal years, and interim periods within those years, beginning after 15 December 2012 for public companies, with early adoption permitted. The adoption of this update did not have a material effect on the Company’s interim consolidated financial statements
Recent Accounting Pronouncements	'
	2.17    Recent Accounting Pronouncements
	In July 2013, the FASB issued ASU No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”, which is intended to eliminate the diversity that is in practice with regard to the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU No. 2013-11 is effective for fiscal years and interim periods within those years, beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.
	In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers”, which provides a five-step approach to be applied to all contracts with customers. ASU No. 2014-09 also requires expanded disclosures about revenue recognition. ASU No. 2014-09 is effective for annual reporting periods beginning after 15 December 2016, including interim periods. Early adoption is not permitted. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.
	In June 2014, the FASB issued ASU No. 2014-10, “Development Stage Entities”, which intends to remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the update eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. ASU No. 2014-10 is effective for fiscal years and interim periods beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.
Reclassifications	'
	2.18    Reclassifications
	Certain amounts reported in previous periods have been reclassified to conform to the current presentation.
Other	'
	2.19    Other
	The Company consists of one reportable business segment.
	The Company paid no dividends during the periods presented.

WEBSITE_Tables

WEBSITE (Tables)	6 Months Ended
	31-May-14
Notes to Financial Statements	'
WEBSITE	'
	As at:	31-May-14			30-Nov-13
					(Audited)
		Cost	Accumulated amortization	Net book value	Cost	Accumulated amortization	Net book value
		$	$	$	$	$	$
	Website	10,000	5,834	4,166	10,000	4,167	5,833
	Total	10,000	5,834	4,166	10,000	4,167	5,833

ACCOUNTS_PAYABLE_AND_ACCRUED_L1

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	6 Months Ended
	31-May-14
Notes to Financial Statements	'
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	'
	As at:	31-May	30-Nov-13
		2014	(Audited)
		$	$
	Accounts payable	28,180	574,188
	Accrued liabilities	14,000	27,000
	Payroll taxes payable	26,428	17,084
	Salaries and benefits payable (Note 6)	534,000	1,044,000
	Total accounts payable and accrued liabilities	602,608	1,662,272

NOTES_PAYABLE_AND_ACCRUED_INTE1

NOTES PAYABLE AND ACCRUED INTEREST (Tables)	6 Months Ended
	31-May-14
Notes to Financial Statements	'
NOTES PAYABLE AND ACCRUED INTEREST	'
	As at:	31-May-14	30-Nov-13
		$	(Audited)
			$
	During the year ended 30 November 2010, Fotoview Inc. (“Fotoview”) issued a loan of $16,000 to a former director of the Company to purchase 4,000,000 restricted common shares of the Company.  Upon the director’s resignation, the 4,000,000 common shares were cancelled and the Company assumed the loan payable to Fotoview.  The loan is unsecured, bears no interest, and has no fixed terms of repayment.	16,000	16,000
	On 21 September 2011, PSI Services (“PSI”) issued a loan of $500 to the Company. The loan is unsecured, bears no interest and has no fixed terms of repayment.	500	500
	On 13 November 2011, PSI issued a loan of CAD$45,000 to the Company.  The loan is unsecured and bears interest at a rate of 6% per annum. Principal and accrued interest are due on 30 November 2014.  During the six month period ended 31 May 2014, the Company accrued interest expense of $1,107 (31 May 2013 - $1,254) (Note 12).  The loan payable to PSI as at 31 May 2014 consists of principal and accrued interest of $41,512 (30 November 2013 – $42,710) and $6,347 (30 November 2013 – $5,251), respectively.	47,859	47,961
	On 1 June 2012, PSI issued a loan of CAD$20,000 to the Company.  The loan is unsecured and bears interest at a rate of 6% per annum.  Principal and accrued interest is due on 30 November 2014.  During the six months ended 31 May 2014, the Company accrued interest expense of $492 (31 May 2013 - $558) (Note 12). The loan payable to PSI as at 31 May 2014 consists of principal and accrued interest of $18,450 (30 November 2013 – $18,982) and $2,211 (30 November 2013 – $1,707), respectively.	20,661	20,689
	On 22 October 2013, PSI issued a loan of USD$3,700 to the Company. The loan is unsecured, bears no interest, and has no fixed terms of repayment.	3,700	3,700
	On 21 April 2014, PSI issued a loan of USD$8,000 to the Company.  The loan is unsecured, bears no interest, and has no fixed terms of repayment.	8,000	-
	Total notes payable	96,720	88,850

GENERAL_AND_ADMINISTRATION_EXP1

GENERAL AND ADMINISTRATION EXPENSES (Tables)	6 Months Ended
	31-May-14
Notes to Financial Statements	'
GENERAL AND ADMINISTRATION EXPENSES	'
		Three month period ended 31 May 2014	Six month period ended 31 May 2014	Three month period ended 31 May 2013	Six month period ended 31 May 2013	Cumulative from re-entering of development stage on
		$	$	$	$	26-Jun-10
						to 31 May 2014
						$
	Administration	-	-	-	-	20
	Amortization (Note 3)	834	1,667	833	1,667	5,834
	Bank charges	51	134	84	156	1,418
	Dues and subscription	-	-	-	-	575
	Filing fees	5,257	5,978	3,203	3,228	17,448
	Meals and entertainment	-	-	-	-	254
	Office	431	500	132	329	7,223
	Penalties	-	-	-	-	10,000
	Transfer agent	255	550	90	240	4,051
	Rent	223	492	545	738	1,725
	Share-based payment	-	-	-	-	8,000
	Telecommunication	1,257	2,057	621	682	5,050
	Travel	-	-	1,097	1,505	2,656
	Website	-	-	-	-	149
	Total general and administration expenses	8,308	11,378	6,605	8,545	64,403

INCOME_TAXES_Tables

INCOME TAXES (Tables)	6 Months Ended
	31-May-14
Income Tax Disclosure [Abstract]	'
Provision for income taxes	'
		For the six month period ended 31 May 2014	For the six month period ended 31 May 2013
		$	$
	Income (loss) before income taxes	971,653	-492,438
	Federal income tax rates	35.00%	35.00%
	Income tax expense (recovery) based on the above rates	340,079	-172,353
	Non–deductible items	15,750	-
	Change in valuation allowance	-355,829	172,353
	Income tax expense	-	-
Deferred tax balances	'
	As at:	31-May	30-Nov-13
		2014	(Audited)
		$	$
	Net income tax operating loss carry-forward	959,254	1,975,908
	Deferred tax assets	335,739	691,568
	Valuation allowance	-335,739	-691,568
	Deferred tax assets (liabilities)	-	-

SUPPLEMENTAL_CASH_FLOW_INFORMA1

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	6 Months Ended
	31-May-14
Notes to Financial Statements	'
Cash payments for interest and income taxes	'
		Three month period ended 31 May 2014	Six month period ended 31 May 2014	Three month period ended 31 May 2013	Six month period ended 31 May 2013
		$	$	$	$
	Interest paid	-	-	-	-
	Taxes paid	-	-	-	-
	Total cash payments	-	-	-	-

WEBSITE_Details_Narrative

WEBSITE (Details Narrative) (USD $)	3 Months Ended	6 Months Ended
	Mar. 31, 2013	31-May-14
Notes to Financial Statements	'	'
Amortization expense	$1,667	$1,667

ACCOUNTS_PAYABLE_AND_ACCRUED_L2

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details Narrative) (USD $)	31-May-14	Nov. 30, 2013
Notes to Financial Statements	'	'
Salaries and benefits payable	$534,000	$1,044,000
Accounts payable and accrued liabilities	32,180	591,188
Income tax filings and accrued	$10,000	$10,000

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)	3 Months Ended	6 Months Ended
	Nov. 30, 2013	31-May-14
Related Party Transactions [Abstract]	'	'
Related parties includes payable	$1,044,000	$534,000
Salaries and benefits earned	612,000	306,000
Accrued salaries and benefits	612,000	306,000
Salaries and benefits, bonuses	300,000	'
Consulting fees	300,000	'
Outstanding and payable	$545,000	'

INTANGIBLE_ASSETS_AND_INTELLEC1

INTANGIBLE ASSETS AND INTELLECTUAL PROPERTY (Details Narrative)	Dec. 04, 2011	Aug. 23, 2011
Notes to Financial Statements	'	'
Common shares	30,000,000	75,000,000
Total of common shares	30,000,000	75,000,000

CAPITAL_STOCK_Details_Narrativ

CAPITAL STOCK (Details Narrative) (USD $)	31-May-14	Apr. 03, 2014	Mar. 11, 2014	Mar. 03, 2014	Dec. 03, 2013	Jul. 18, 2013	Apr. 26, 2013	Apr. 10, 2013	Oct. 08, 2010	Jun. 02, 2010
Notes to Financial Statements	'	'	'	'	'	'	'	'	'	'
Shares of common stock	$675,000,000	'	'	'	'	'	'	'	$675,000,000	'
Per share	$0.00	'	'	'	'	'	$0.00	'	$0.00	'
Authorized share	'	'	'	'	'	'	'	'	75,000,000	'
Additional shares issued	'	'	'	'	'	'	'	'	'	208,800,000
Company issued shares	'	10,000	5,000	10,000	10,000	25,000	2,000,000	20,000	'	'
Cash proceeds	'	10,000	5,000	10,000	10,000	25,000	'	20,000	'	'
Share issuance costs	'	'	'	'	'	'	'	$2,000	'	'

INCOME_TAXES_Details_Narrative

INCOME TAXES (Details Narrative) (USD $)	31-May-14	Nov. 30, 2013
Income Tax Disclosure [Abstract]	'	'
Total non-capital loss	$959,254	$1,975,908

COMMITMENTS_AND_CONTINGENCY_De

COMMITMENTS AND CONTINGENCY (Details Narrative) (USD $)	31-May-14	Nov. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'	'
Outstanding and payable	'	$545,000
Paying monthly salaries	51,000	51,000
Income tax accrued	$10,000	$10,000

SUPPLEMENTAL_CASH_FLOW_INFORMA2

SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) (USD $)	3 Months Ended	6 Months Ended
	Mar. 31, 2013	31-May-14	Apr. 26, 2013	Nov. 13, 2011
Notes to Financial Statements	'	'	'	'
Company issued	'	'	$2,000,000	'
Common stock par value	'	'	$0.00	'
Company recorded consulting expense	'	'	2,000	'
Accrued interest expense	1,254	1,107	'	'
Loan issued	'	'	'	$45,000